StockData
Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc. (CAPR) stock

CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.03−0.38 (-4.52%)

Close on Nov 18, 2026Market cap $466.86MP/E –Yield –

Capricor Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Capricor Therapeutics's price to sales ratio was 26.0× on Apr 30, 2025, against 6.5× a year earlier. Over the last 5 years it ranged from 3.7× to 407.2×, with a median of 24.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 202526.0×+2.0
2024Dec 31, 202424.0×+15.0
2023Dec 29, 20239.0×−304.1
2022Apr 29, 2022313.1×+79.3
2021Dec 31, 2021233.7×+87.6
2020Dec 31, 2020146.1×+142.4
2019Dec 31, 20193.7×−4.7
2018Dec 31, 20188.4×−4.4
2017Dec 29, 201712.8×−0.7
2016Dec 30, 201613.5×+4.9
2015Dec 31, 20158.6×−4.4
2014Dec 31, 201413.0×−53.2
2013Dec 31, 201366.1×+1.3
2012Dec 31, 201264.8×–

More Capricor Therapeutics figures

See a number that looks wrong?